Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Sher · SciRah

Researcher profile · Semantic Scholar

T. Sher

Share profile

T. Sher — researcher profile on SciRah

h-index: 32
Works: 219
Citations: 4,510

Most-cited papers

A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma.
N. Bartlett, A. Herrera, E. Domingo-Domènech, A. Mehta +15 more
2020Blood133 citations Open access
Semantic Scholar
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update.
Eli Muchtar, A. Dispenzieri, M. Gertz, Shaji K. Kumar +34 more
2021Mayo Clinic proceedings75 citations Open access
Semantic Scholar
Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia
Vivek Kumar, S. Ailawadhi, Leyla Bojanini, Aditya Mehta +13 more
2019Blood Cancer Journal67 citations Open access
Semantic Scholar
A Retrospective Analysis of Gender-Based Difference in Adherence to Influenza Vaccination during the 2018-2019 Season
Andres I. Applewhite, F. Stancampiano, D. Harris, Alyssa Manaois +6 more
2020Journal of Primary Care & Community Health50 citations Open access
Semantic Scholar
Multiple Myeloma in the Time of COVID-19
Abdullah S. Al Saleh, T. Sher, M. Gertz
2020Acta Haematologica50 citations Open access
Semantic Scholar
“Real-life” data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma—the Mayo Clinic experience
I. Vaxman, J. Abeykoon, A. Dispenzieri, S. Kumar +21 more
2021Blood Cancer Journal49 citations Open access
Semantic Scholar
Autologous Stem-Cell Transplantation for Multiple Myeloma in the Era of Novel Therapies.
Ricardo D. Parrondo, S. Ailawadhi, T. Sher, A. Chanan-Khan +1 more
2020JCO Oncology Practice36 citations
Semantic Scholar
Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses.
Alak Manna, Timothy M. Kellett, Sonikpreet Aulakh, Laura J. Lewis-Tuffin +11 more
2020Blood Advances34 citations Open access
Semantic Scholar
Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis.
Vivek Kumar, M. Ailawadhi, Navnita Dutta, Mays F. Abdulazeez +9 more
2020Clinical Lymphoma, Myeloma & Leukemia33 citations
Semantic Scholar
Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia
J. Abeykoon, S. Zanwar, S. Ansell, Eli Muchtar +28 more
2021American journal of hematology/oncology30 citations Open access
Semantic Scholar
Efficacy of Allogeneic Hematopoietic Cell Transplantation in Human T Cell Lymphotropic Virus Type 1-Associated Adult T Cell Leukemia/Lymphoma: Results of a Systematic Review/Meta-Analysis.
M. Iqbal, T. Reljic, Farina A. Klocksieben, T. Sher +5 more
2019Biology of Blood and Marrow Transplantation26 citations Open access
Semantic Scholar
Risk factors for severe infection and mortality In patients with COVID‐19 in patients with multiple myeloma and AL amyloidosis
M. Ho, S. Zanwar, F. Buadi, S. Ailawadhi +26 more
2022American journal of hematology/oncology23 citations Open access
Semantic Scholar
Timeliness of Initial Therapy in Multiple Myeloma: Trends and Factors Affecting Patient Care.
Vivek Kumar, Muhamad Alhaj-Moustafa, Leyla Bojanini, T. Sher +13 more
2020JCO Oncology Practice22 citations
Semantic Scholar
Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety
Saurav Das, S. Ailawadhi, T. Sher, Vivek Roy +2 more
2023Current Oncology21 citations Open access
Semantic Scholar
Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting
T. Jayakrishnan, Sonikpreet Aulakh, Mizba Baksh, Kianna Nguyen +9 more
2021Cancers18 citations Open access
Semantic Scholar
Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia.
Ricardo D. Parrondo, M. Moustafa, C. Reeder, T. Sher +10 more
2021Clinical Lymphoma, Myeloma & Leukemia17 citations
Semantic Scholar
Midostaurin therapy for advanced systemic mastocytosis: Mayo Clinic experience in 33 consecutive cases
Amritpal Singh, A. Al-Kali, K. Begna, M. Litzow +8 more
2022American journal of hematology/oncology16 citations
Semantic Scholar
Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
P. Hampel, K. Rabe, T. Call, W. Ding +17 more
2022Blood Cancer Journal14 citations Open access
Semantic Scholar
Impact of Cytogenetic Abnormalities on the Risk of Disease Progression in Solitary Bone Plasmacytomas.
U. Yadav, Shaji K. Kumar, L. Baughn, A. Dispenzieri +29 more
2023Blood13 citations Open access
Semantic Scholar
Comparable Efficacy of Reduced Dose Radiation Therapy for the Treatment of Early Stage Gastric Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
O. Saifi, S. Lester, W. Rule, B. Stish +11 more
2021Advances in Radiation Oncology13 citations Open access
Semantic Scholar
A Retrospective Analysis of Gender-Based Difference in Adherence to Initial Colon Cancer Screening Recommendations
J. Valery, Andres I. Applewhite, Alyssa Manaois, J. Dimuna +4 more
2020Journal of Primary Care & Community Health13 citations Open access
Semantic Scholar
Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes
A. Bolarinwa, Madhu Nagaraj, S. Zanwar, N. Abdallah +31 more
2025Blood Cancer Journal12 citations Open access
Semantic Scholar
Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities
S. Ailawadhi, Yaw Adu, R. D. Frank, Saurav Das +8 more
2024Blood Cancer Journal12 citations Open access
Semantic Scholar
Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities.
S. Ailawadhi, A. Azzouqa, D. Hodge, J. Cochuyt +12 more
2019Clinical Lymphoma, Myeloma & Leukemia12 citations
Semantic Scholar
Prevention Of Skeletal Related Events In Multiple Myeloma: Focus On The RANK-L Pathway In The Treatment Of Multiple Myeloma
Ricardo D. Parrondo, T. Sher
2019OncoTargets and Therapy12 citations Open access
Semantic Scholar
Trends in participant race and sex reporting in lung cancer phase III clinical trials
F. Aslam, R. Manochakian, Y. Lou, G. Colón-Otero +1 more
2023Cancer Reports11 citations Open access
Semantic Scholar
Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma
Ricardo D. Parrondo, Z. Rahman, M. Heckman, Mikolaj Wieczorek +13 more
2022Blood Cancer Journal10 citations Open access
Semantic Scholar
RETRACTED ARTICLE: Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis
Ricardo D. Parrondo, Keren Sam, A. Rasheed, Victoria R. Alegria +4 more
2022Blood Cancer Journal10 citations Open access
Semantic Scholar
Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review
Ricardo D. Parrondo, V. Roy, T. Sher, Victoria R. Alegria +2 more
2020Case Reports in Hematology9 citations Open access
Semantic Scholar
First Report of Hereditary Lysozyme Amyloidosis in a South Asian Family
M. Iqbal, Prachi Jani, Salman Ahmed, T. Sher
2019Case Reports in Hematology9 citations Open access
Semantic Scholar
Therapeutic Outcomes of Relapsed-Refractory Multiple Myeloma Patients with 1q21+Treated with Daratumumab-Based Regimens: A Retrospective Analysis
Ricardo D. Parrondo, Lindsay B. Gardner, Mohamad Alhaj Moustafa, V. Roy +10 more
2022Blood8 citations Open access
Semantic Scholar
COVID-19 and Vulnerable Population With Communication Disorders
T. Sher, Greta C. Stamper, L. Lundy
2020Mayo Clinic proceedings8 citations Open access
Semantic Scholar
AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma
S. Ailawadhi, Ricardo D. Parrondo, Navnita Dutta, Bing Han +17 more
2023Cancers7 citations Open access
Semantic Scholar
Ibrutinib, lenalidomide and dexamethasone in patients with relapsed and/or refractory multiple myeloma: Phase I trial results
S. Ailawadhi, Ricardo D. Parrondo, M. Moustafa, B. Laplant +6 more
2022Hematological Oncology7 citations
Semantic Scholar
Results of a completed phase I study of LAM-002 (apilimod dimesylate), a first-in-class phosphatidylinositol-3-phosphate 5 kinase (PIKfyve) inhibitor, administered as monotherapy or with rituximab or atezolizumab to patients with previously treated follicular lymphoma or other B-cell cancers.
Catherine S. Magid Diefenbach, J. Cohen, W. Harb, S. Ansell +16 more
20207 citations
Semantic Scholar
V122I Transthyretin Cardiomyopathy: An Opportunity to Build Trust and Resolve Disparities.
T. Sher, G. Velarde, M. Gertz
2020Journal of the American College of Cardiology7 citations Open access
Semantic Scholar
Algorithms and Bioethics.
T. Sher, R. Sharp, R. Wright
2020Mayo Clinic proceedings7 citations Open access
Semantic Scholar
Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation in patients with multiple myeloma: a single center experience
Farah Yassine, M. Kharfan-Dabaja, Athanasios Tsalantsanis, V. Roy +7 more
2023Bone Marrow Transplantation6 citations Open access
Semantic Scholar
A Panel Evaluation of the Changes in the General Public’s Social-Media-Following of United States’ Public Health Departments during COVID-19 Pandemic
Areej Khokhar, Aaron C. Spaulding, Zuhair Niazi, S. Ailawadhi +4 more
2021Journal of Primary Care & Community Health6 citations Open access
Semantic Scholar
Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance
M. Ho, S. Zanwar, F. Buadi, S. Ailawadhi +26 more
2022Blood5 citations Open access
Semantic Scholar
Antibody‐based immunotherapy for treatment of immunoglobulin light‐chain amyloidosis
Ricardo D. Parrondo, U. Majeed, T. Sher
2020British Journal of Haematology5 citations
Semantic Scholar
Trends in Early Mortality from Multiple Myeloma (MM): A Population-Based Analysis
Vivek Kumar, Mays F. Abdulazeez, Suman Biswas, S. Bodepudi +9 more
2019Blood5 citations Open access
Semantic Scholar
The digital divide: Racial disparities in adoption and utilization of health information technology among patients with lymphoid cancers
S. Ailawadhi, M. Ailawadhi, Navnita Dutta, Ricardo D. Parrondo +8 more
2023Cancer Medicine4 citations Open access
Semantic Scholar
Patient Awareness of CAR-T and Bispecific Antibody Treatments for Multiple Myeloma: Real-World Learnings and Disparities
Yaw Adu, Saurav Das, Dhaani Ailawadhi, Andre Fernandez +7 more
2023Blood4 citations Open access
Semantic Scholar
Phase II Trial of Elotuzumab with Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM) in the Post-Daratumumab Progression Setting
S. Ailawadhi, Ricardo D. Parrondo, B. Laplant, Victoria R. Alegria +7 more
2022Blood4 citations Open access
Semantic Scholar
Phase II Study of Ibrutinib in Combination with Ixazomib in Patients with Waldenström Macroglobulinemia (WM)
S. Ailawadhi, Ricardo D. Parrondo, B. Laplant, Victoria R. Alegria +9 more
2022Blood4 citations Open access
Semantic Scholar
Kidney Transplantation and Monoclonal Gammopathy of Undetermined Significance
N. Aslam, Christopher L. Trautman, T. Sher
2021Transplantation Direct4 citations Open access
Semantic Scholar
Utilization of radiation therapy in multiple myeloma: trends and changes in practice
S. Ailawadhi, R. Frank, M. Ailawadhi, Zahara Kanji +12 more
2021Annals of Hematology4 citations
Semantic Scholar
Resuscitation and COVID-19: Recalibrating Patient and Family Expectations During a Pandemic
T. Sher, C. Burger, E. DeMartino, A. G. de Moraes +1 more
2020Mayo Clinic proceedings4 citations Open access
Semantic Scholar
Phase I Study of a Novel Bcl-2 Inhibitor, at-101 in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)
S. Ailawadhi, Victoria R. Alegria, Salman Ahmed, B. Laplant +9 more
2019Blood4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Chanan-Khan×25
Invite
A. Chanan-Khan — researcher profile on SciRah
V. Roy×24
Invite
V. Roy — researcher profile on SciRah
Ricardo D. Parrondo×22
Invite
Ricardo D. Parrondo — researcher profile on SciRah
S. Ailawadhi×20
Invite
S. Ailawadhi — researcher profile on SciRah

Victoria R. Alegria

×14

Invite

Victoria R. Alegria — researcher profile on SciRah

Invite

A. Paulus — researcher profile on SciRah

S. Ailawadhi×12

Invite

S. Ailawadhi — researcher profile on SciRah

Invite

Eli Muchtar — researcher profile on SciRah

Invite

D. Dingli — researcher profile on SciRah

Invite

P. Kapoor — researcher profile on SciRah

W. Gonsalves×8

Invite

W. Gonsalves — researcher profile on SciRah

Invite

R. Warsame — researcher profile on SciRah